from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0076c/-

LFCtreatmentdescriptionclass of inhibitor

-1.157

Amikacinug/mL Amikacintranslation

0.098

Cap5-10ug/mL Capreomycintranslation

1.811

Rox10-50 ug/mL Roxithromycintranslation

0.287

SM2-5 ug/mL Streptomycintranslation

-0.680

Tet5-10 ug/mL Tetracyclinetranslation

-1.360

Rif0.2-5ug/mL Rifampicintranscription

-1.030

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.999

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.207

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.457

CPZ10-50 ug/mL Chlorpromazinerespiration

0.114

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.095

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

5.393

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.191

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.035

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.144

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.126

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.159

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.169

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.152

KCN5-20 ug/mL Potassium cyaniderespiration

-0.468

NaN30.2-2 mM Sodium aziderespiration

0.070

Nigericin50 uM Nigericinrespiration

0.814

TRC10-150 ug/mL Triclosanrespiration

-0.173

TRZ10-25 ug/mL Thioridazinerespiration

1.105

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.265

menadione6-10 ug/mL Menadionerespiration

0.353

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.291

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.123

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.415

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.333

NRP_1Non-replicating persistence stage 1dosRassociated

0.093

Amp0.2mg/mL AmpicillincellWall

-0.164

Cephalexin20-100 ug/mL CephalexincellWall

0.312

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.068

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.837

EMB10-20 ug/mL EthambutolcellWall

-0.113

Eta12-40 ug/mL EthionamidecellWall

-0.714

INH0.2-0.4 ug/mL IsoniazidcellWall

0.074

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.042

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.401

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.212

BZA0.12 mg/mL BenzamidearomaticAmides

-0.093

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.446

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.235

H2O24 mM hydrogen peroxideDNAdamaging

0.127

Levo10 ug/mL LevofloxacinDNAdamaging

0.033

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.115

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.017

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.023

UVUV-irradiationDNAdamaging

-0.052

ARP41-4 ug/mL Antitubercular compound ARP4?

0.208

Antimycin12.5-50 ug/mL Antimycin A?

-0.157

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.360

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.122

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.789

PA8240.2-2 ug/mL PA-824?

-0.008

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.521

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.155

mercaptoethanol2 mM 2-Mercaptoethanol?

0.342

methoxatin10-20 ug/mL Methoxatin?